霍乱病毒病毒的毒性被基托寡糖介导的ChsR活性抑制所阻断
Yutao Liu1, Jialin Wu2, Ruiying Liu1
1National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, TEDA Institute of Biological Sciences and Biotechnology, Nankai University, Tianjin, People's Republic of China.
基托桑利用调节器ChsR通过调节TcpP来增强Vibrio cholerae的毒性. 酸寡糖抑制了这种途径,减少了小鼠的霍乱严重程度和殖民.
科学领域:
- 微生物学 微生物学
- 分子生物学分子生物学
- 病原体研究 病原体研究
背景情况:
- 霍乱是由Vibrio cholerae引起的,仍然是一个重大的全球健康威胁.
- 了解毒性调节是开发新型霍乱治疗方法的关键.
- 针对毒性因子提供了传统抗生素治疗的替代方案.
研究的目的:
- 调查基托利用调节器ChsR在V.霍乱病毒毒性的作用.
- 阐明ChsR影响霍乱病变的分子机制.
- 评估基托衍生物在打击霍乱方面的治疗潜力.
主要方法:
- 使用野生型和突变的V. 霍乱菌株进行竞争性感染.
- 配序的RNA测序和染色体免疫沉与测序 (ChIP-seq).
- 霍乱的体内小鼠模型,以评估殖民和疾病的严重程度.
主要成果:
- 在生物体中,ChsR被确定为V. cholerae毒性的积极调节者.
- 在低氧条件下,ChsR直接对毒性调节器TcpP进行上调,促进霍乱毒素和毒素共同调节的皮卢斯表达.
- 发现酸盐降解产品可以抑制ChsR-tcpP促进剂相互作用.
- 基托寡糖的使用,特别是通过微球载体,减少了小鼠的肠道殖民和疾病严重程度.
结论:
- 通过调节TcpP通路,ChsR在V. cholerae病毒性中发挥着关键作用.
- 奇托寡糖体显示出作为霍乱治疗和预防的补充疗法的潜力.
- 向ChsR介导的途径为控制霍乱提供了一个有希望的策略.
更多相关视频
09:39Determination of Tolerable Fatty Acids and Cholera Toxin Concentrations Using Human Intestinal Epithelial Cells and BALB/c Mouse Macrophages
Published on: May 30, 2013
07:58Laboratory Techniques Used to Maintain and Differentiate Biotypes of Vibrio cholerae Clinical and Environmental Isolates
Published on: May 30, 2017
相关概念视频
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Gene Regulation in Microbial Communities: Quorum Sensing
Hand hygiene
Hand washing...
